172 related articles for article (PubMed ID: 32844883)
1. CHRONIC USE OF PROTON PUMP INHIBITORS AND THE QUANTITY OF G, D, AND ECL CELLS IN THE STOMACH.
Camilo SMP; Almeida ÉCS; Sousa JB; Camilo LP; Etchebehere RM
Arq Bras Cir Dig; 2020; 33(2):e1506. PubMed ID: 32844883
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells.
Yokota T; Matsui H; Matsuura B; Maeyama K; Onji M
Eur J Pharmacol; 2003 Nov; 481(2-3):233-40. PubMed ID: 14642791
[TBL] [Abstract][Full Text] [Related]
3. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
[TBL] [Abstract][Full Text] [Related]
4. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.
Waldum HL; Rehfeld JF
Scand J Gastroenterol; 2019 Sep; 54(9):1118-1123. PubMed ID: 31524029
[TBL] [Abstract][Full Text] [Related]
7. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
[TBL] [Abstract][Full Text] [Related]
8. Effects of Proton Pump Inhibitor Therapy,
Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
[TBL] [Abstract][Full Text] [Related]
9. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.
Konagaya T; Bernsand M; Norlén P; Håkanson R
Br J Pharmacol; 2001 May; 133(1):37-42. PubMed ID: 11325792
[TBL] [Abstract][Full Text] [Related]
11. Gastrin and the enterochromaffin-like cell: an acid update.
Kidd M; Modlin IM; Tang LH
Dig Surg; 1998; 15(3):209-17. PubMed ID: 9845587
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic and histopathologic gastric changes in chronic users of proton-pump inhibitors.
Camilo SM; Almeida ÉC; Miranzi BA; Silva JC; Nomelini RS; Etchebehere RM
Arq Gastroenterol; 2015; 52(1):59-64. PubMed ID: 26017085
[TBL] [Abstract][Full Text] [Related]
13. A hypothesis of couplet molecules and couplet cells in gastric function and an association with Helicobacter pylori.
Craven CJ
BMC Gastroenterol; 2016 Feb; 16():16. PubMed ID: 26879837
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
15. The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin.
Helgadóttir H; Metz DC; Yang YX; Rhim AD; Björnsson ES
Dig Liver Dis; 2014 Feb; 46(2):125-30. PubMed ID: 24210828
[TBL] [Abstract][Full Text] [Related]
16. Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors.
Larkin CJ; Watson RGP ; Sloan JM; Stevenson M; Ardill JE; Buchanan D
Scand J Gastroenterol; 2000 Jun; 35(6):578-82. PubMed ID: 10912656
[TBL] [Abstract][Full Text] [Related]
17. Hypergastrinemia Expands Gastric ECL Cells Through CCK2R
Sheng W; Malagola E; Nienhüser H; Zhang Z; Kim W; Zamechek L; Sepulveda A; Hata M; Hayakawa Y; Zhao CM; Chen D; Wang TC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):434-449.e1. PubMed ID: 32330731
[TBL] [Abstract][Full Text] [Related]
18. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
19. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
20. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
